Body fluid matrix evaluation on a Roche cobas 8000 system.

Area of Science:

• Clinical Chemistry
• Diagnostic Laboratory Science
• Medical Diagnostics

Background:

• Physicians frequently order chemical analyses of body fluids.
• Commercial clinical laboratory assays often lack validation for non-serum/non-plasma specimens.
• Laboratories must conduct validation studies for body fluid testing to meet regulatory standards.

Purpose of the Study:

• To evaluate potential matrix interferences in body fluid specimens for common chemistry analytes.
• To perform recovery studies to assess the accuracy of testing various body fluid types.
• To provide data supporting the validation of body fluid testing assays.

Main Methods:

• Utilized IRB-approved, de-identified clinical body fluid specimens (e.g., cerebrospinal, synovial, pleural).
• Conducted recovery studies by spiking specimens with serum, controls, or calibrators.
• Analyzed specimens using the Roche cobas 8000 system.

Main Results:

• Investigated 80 analyte/body fluid combinations.
• Average percent recovery for all combinations was within acceptable limits (±10%).
• No systematic matrix interference was detected for the tested analytes and body fluids.

Conclusions:

• The Roche cobas 8000 system demonstrated reliable performance for the analyzed body fluid chemistry tests.
• Results indicate minimal matrix effects, supporting the use of these assays in body fluid analysis.
• Findings reinforce the importance of validation initiatives for regulatory compliance in clinical laboratories.